1 completed, 1 enrolling by invitation. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Enrolling by invitation 1 |
Follow Cefadroxil: new trials by email Literature Review of Cefadroxil trials Research Report on Cefadroxil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Or v IV Antibiotics for Infection Bactrim, Cefadroxil, Doxycycline Hcl - Joint Infection | Phase 3 | Enrolling by invitation | Rothman Institute Orthopaedics | 308 | 2021-01-25 | 2026-10-08 |
| Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Dalbavancin, Vancomycin, Oxacillin - Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections | Phase 3 | Completed | AbbVie | 199 | 2017-03-30 | 2024-09-19 |
Bacterial Infections (1) · Staphylococcal Skin Infections (1)
AbbVie (1) · Rothman Institute Orthopaedics (1)
United States (2) · Argentina (1) · Belarus (1) · Brazil (1) · Bulgaria (1) · Chile (1) · Colombia (1) · Georgia (1) · Greece (1) · Guatemala (1) · Latvia (1) · Lithuania (1) · Mexico (1) · Panama (1) · Poland (1)
2014 (1)